TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/19/25 17:44 | 2/14/25 | AARD | Aardvark Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Decheng Capital Global Life Sciences Fund Iv, L.P. | E9 | T | P.d | 20,000 | 16.00 | 0 | 1,250 | 47 | 3,917 | I | |||||||||||||||
4/9/24 19:08 | 1/29/24 | CGON | Cg Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Decheng Capital Global Life Sciences Fund Iv, L.P. | CA | T | P.a | 7,600 | 19.00 | 0 | 400 | 9 | 4,959 | D | |||||||||||||||
1/31/24 16:17 | 1/29/24 | CGON | Cg Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Decheng Capital Global Life Sciences Fund Iv, L.P. | E9 | T | P.d | 7,600 | 19.00 | 0 | 400 | 9 | 4,959 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |